New search Hide text from Guidelines
G GENITO URINARY SYSTEM AND SEX HORMONESG03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
Other hormones, see H - Systemic hormonal preparations, excl. sex hormones and insulins.
Sex hormones used only in the treatment of neoplastic diseases (often selected strengths) are classified in L - Antineoplastic and immunomodulating agents.
| The DDDs of many of the hormone preparations may vary considerably with the route of administration due to substantial differences in bioavailability. The DDDs of depot preparations are calculated as the dose divided by the dosing interval. |
G03B ANDROGENS
Anabolic steroids, see A14A. Norethandrolone, which has both anabolic and androgenic effects, is classified in A14A since the anabolic effect is considered to be the most important effect.
This group comprises male sex hormones. Combined preparations are included in this group, except combinations with female sex hormones, which are classified in G03E - Androgens and female sex hormones in combination.
The group is subdivided according to chemical structure.
| The DDDs are based on use in substitution therapy in male hypogonadism. The DDDs for patches (e.g. testosterone) are given in amount delivered. |
G03BA 3-oxoandrosten (4) derivatives
| The DDD for parenteral and oral testosterone is expressed as declared amount of ester. The DDD for TD and SL route of administration is expressed as declared amount of testosterone. |
| ATC code | Name | DDD | U | Adm.R | Note |
| G03BA01 | fluoxymesterone | 5 | mg | O | |
| G03BA02 | methyltestosterone | 25 | mg | O | |
| G03BA03 | testosterone | 0.12 | g | O | |
| 18 | mg | P | |||
| 0.12 | g | R | |||
| 60 | mg | SL | |||
| 50 | mg | TD | gel | ||
| 3 | mg | TD |
Last updated: 2024-01-26